Cargando…
Aspartyl Protease Inhibitors as Anti-Filarial Drugs
The current treatments for lymphatic filariasis and onchocerciasis do not effectively kill the adult parasitic nematodes, allowing these chronic and debilitating diseases to persist in millions of people. Thus, the discovery of new drugs with macrofilaricidal potential to treat these filarial diseas...
Autores principales: | Beld, Liana, Jung, Hyeim, Bulman, Christina A., Rosa, Bruce A., Fischer, Peter U., Janetka, James W., Lustigman, Sara, Sakanari, Judy A., Mitreva, Makedonka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227574/ https://www.ncbi.nlm.nih.gov/pubmed/35745561 http://dx.doi.org/10.3390/pathogens11060707 |
Ejemplares similares
-
An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical Disease
por: Tyagi, Rahul, et al.
Publicado: (2021) -
Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics
por: Tyagi, Rahul, et al.
Publicado: (2019) -
De novo identification of toxicants that cause irreparable damage to parasitic nematode intestinal cells
por: Jasmer, Douglas P., et al.
Publicado: (2020) -
Efficacy of subcutaneous doses and a new oral amorphous solid dispersion formulation of flubendazole on male jirds (Meriones unguiculatus) infected with the filarial nematode Brugia pahangi
por: Fischer, Chelsea, et al.
Publicado: (2019) -
Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis
por: Jawahar, Shabnam, et al.
Publicado: (2021)